KERX Key Stats
|08/07/2014 08:00 EDT||Misc||Keryx Biopharmaceuticals Inc Q2 2014 Earnings Conference Call|
|08/07/2014||Earnings||Keryx Biopharmaceuticals Inc Q1 2014 Earnings Results|
|06/23/2014||Misc||Annual General Meeting for Keryx Biopharmaceuticals Inc|
|05/08/2014 08:00 EDT||Misc||Keryx Biopharmaceuticals Inc Q1 2014 Earnings Conference Call|
|05/08/2014||Earnings||Keryx Biopharmaceuticals Inc Q1 2014 Earnings Results|
|03/13/2014 08:30 EDT||Misc||Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call|
|03/13/2014||Earnings||Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Results|
|11/05/2013 08:30 EDT||Misc||Q3 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call|
|11/04/2013||Earnings||Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results|
KERX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Keryx Biopharmaceuticals is up 41.30% over the last year vs S&P 500 Total Return up 13.58%, Gilead Sciences up 56.38%, and China Biologic Products up 76.14%.
Balance Sheet View Statement
Y-Ratings for KERX
PDF Report for KERX
Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download KERX Pro Report PDF
Portfolio Strategies Featuring KERX
Did Keryx Biopharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.keryx.com
- IR Website: http://www.keryx.com/investor-relations/
- HQ Country: United States
- HQ State/Province: New York
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: December 31, 2014
- Est. Current Fiscal Year End: December 31, 2014
- Last Fiscal Quarter End: June 30, 2014
- Last Fiscal Year End: December 31, 2013
- NAICS: Pharmaceutical Preparation Manufacturing
- NAICS Code: 325412
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
Keryx Biopharmaceuticals, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It is developing ZerenexTM an oral, ferric iron-based compound.
KERX Excel Add-In Codes
- Name: =YCI("KERX","name")
- Description: =YCI("KERX","description")
- Sector: =YCI("KERX","sector")
- Industry: =YCI("KERX","industry")
- Est. Current Fiscal Year End: =YCI("KERX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.